Direct-to-Consumer Dental Products Advertising: The Role of Evidence-Based Methods

References 

1. Jaeschke R. Evidence-based health care as a model for decision making.
2. FDA Center for Drug Evaluation and Research. Over-the-counter drug products. Available at: www.fda.gov/cder/Offices/OTC/whatwedo.htm. Accessed November 20, 2003.
3. Council on Dental Therapeutics . Guidelines for acceptance of chemotherapeutic products for the control of supragingival dental plaque and gingivitis. J Am Dent Assoc. 1986;112:529–532
   • MEDLINE
4. Imrey PB, Chilton NW, Pihlstrom BL, Proskin HM, Kingman A, Listgarten MA, et al.  Recommended revisions to American Dental Association guidelines for acceptance of chemotherapeutic products for gingivitis control. J Periodont Res. 1994;29:299–304
5. Available at: www.fda.gov/foi/warning-letters/d752b.pdf. Accessed on November 20, 2003.
6. Available at: www.ftc.gov/opa/1998/12/petapp6298.htm. Accessed on November 20, 2003.
7. Available at: www.ftc.gov/opa/1999/05/doans.htm. Accessed on November 20, 2003.
8. ADA Seal Provisions for Acceptance. Available at: www.ada.org/ada/seal/provisions.asp. Accessed on November 20, 2003.
9. Available at: www.nadreview.org/DocView.asp?PageContext=280781091523637&SessionID=0&DocumentID=3942. Accessed on November 20, 2003.
10. Available at: www.nadreview.org/DocView.asp?PageContext=286792254210769792&SessionID=0&DocumentID=4081. Accessed on November 20, 2003.